VNDA
Vanda Pharmaceuticals Inc
4.60$
-1.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 27,030.6% | – | – | – | – | 63.7% | 12.5% | 128.0% | 0.4% | 154.5% | 3.2% | 21.3% | 16.9% | 10.8% | 10.6% | 10.8% | 9.4% | 9.5% | 9.5% | 9.1% | 5.7% | 6.0% | |
| 100.0% | – | – | – | – | 36.3% | 87.5% | 100.0% | 99.6% | 100.0% | 96.8% | 78.7% | 83.1% | 89.2% | 89.4% | 89.2% | 90.6% | 90.5% | 90.5% | 100.0% | 94.3% | 94.0% | |
| 21,904.0% | – | – | – | – | 305.1% | 35.0% | 92.7% | 138.9% | 83.2% | 38.3% | 26.5% | 20.0% | 23.4% | 22.6% | 21.4% | 22.4% | 28.0% | 33.7% | 39.9% | 37.4% | 50.6% | |
| – | – | – | – | – | 521.7% | 28.8% | 36.7% | 42.4% | 72.6% | 158.8% | 73.8% | 67.4% | 74.2% | 54.8% | 55.7% | 51.5% | 43.7% | 52.6% | 63.4% | 72.7% | 110.1% | |
| 28,141.2% | – | – | – | – | 826.7% | 63.8% | 134.2% | 185.8% | 160.2% | 211.6% | 115.2% | 95.8% | 99.4% | 78.1% | 79.2% | 79.6% | 74.8% | 88.0% | 107.2% | 114.8% | 163.9% | |
| -28,041.2% | – | – | – | – | -790.5% | 23.7% | -34.2% | -86.2% | -60.2% | 40.0% | -36.6% | -12.7% | -10.2% | 11.3% | 10.0% | 11.0% | 15.7% | 2.5% | -7.2% | -20.5% | -70.0% | |
| 0.0% | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.7% | 1.8% | 0.1% | 2.0% | – | – | – | |
| -27,867.4% | – | – | – | – | -788.5% | 26.3% | -32.8% | -84.5% | -59.8% | 40.2% | -36.3% | -12.3% | -9.3% | 13.1% | 12.8% | 12.8% | 15.8% | 4.4% | 3.3% | -11.5% | -64.2% | |
| 14.6% | – | – | – | – | – | 5.9% | -1.4% | 0.0% | 0.0% | -154.7% | 0.0% | 0.1% | 0.1% | 0.1% | -38.1% | 3.4% | 3.4% | 2.0% | 2.0% | -2.0% | 37.9% | |
| -27,881.9% | – | – | – | – | -788.5% | 20.4% | -31.3% | -84.5% | -59.8% | 40.2% | -36.3% | -12.3% | -9.4% | 13.1% | 50.9% | 9.4% | 12.3% | 2.5% | 1.3% | -9.5% | -102.0% | |
| -26,932.6% | – | – | – | – | -759.1% | 30.3% | -30.9% | -82.7% | -56.9% | -109.2% | -24.2% | -4.6% | -8.4% | 12.8% | 11.3% | 13.9% | 16.8% | 5.5% | -7.2% | -7.4% | -58.6% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.